Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) can profoundly affect quality of life and are influenced by stress and resiliency. The impact of mind-body interventions (MBIs) on IBS and IBD patients has not previously been examined. METHODS: Nineteen IBS and 29 IBD patients were enrolled in a 9-week relaxation response based mind-body group intervention (RR-MBI), focusing on elicitation of the RR and cognitive skill building. Symptom questionnaires and inflammatory markers were assessed pre- and post-intervention, and at short-term follow-up. Peripheral blood transcriptome analysis was performed to identify genomic correlates of the RR-MBI. RESULTS: Pain Catastrophizing Scale scores improved significantly post-intervention for IBD and at short-term follow-up for IBS and IBD. Trait Anxiety scores, IBS Quality of Life, IBS Symptom Severity Index, and IBD Questionnaire scores improved significantly post-intervention and at short-term follow-up for IBS and IBD, respectively. RR-MBI altered expression of more genes in IBD (1059 genes) than in IBS (119 genes). In IBD, reduced expression of RR-MBI response genes was most significantly linked to inflammatory response, cell growth, proliferation, and oxidative stress-related pathways. In IBS, cell cycle regulation and DNA damage related gene sets were significantly upregulated after RR-MBI. Interactive network analysis of RR-affected pathways identified TNF, AKT and NF-κB as top focus molecules in IBS, while in IBD kinases (e.g. MAPK, P38 MAPK), inflammation (e.g. VEGF-C, NF-κB) and cell cycle and proliferation (e.g. UBC, APP) related genes emerged as top focus molecules. CONCLUSIONS: In this uncontrolled pilot study, participation in an RR-MBI was associated with improvements in disease-specific measures, trait anxiety, and pain catastrophizing in IBS and IBD patients. Moreover, observed gene expression changes suggest that NF-κB is a target focus molecule in both IBS and IBD-and that its regulation may contribute to counteracting the harmful effects of stress in both diseases. Larger, controlled studies are needed to confirm this preliminary finding. TRIAL REGISTRATION: ClinicalTrials.Gov NCT02136745.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713
Self-citationThe functional gastrointestinal disorders and the Rome III process
Drossman, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.008 · Cited by 2,416
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Merico, D., Isserlin, R., Stueker, O., Emili, A., & Bader, G. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013984 · Cited by 2,235 · cited 1×
“The enriched gene sets were merged into functional modules on the basis of overlap of significantly enriched genes using the Enrichment Map [41] Cytoscape Plugin: An Open Source Platform for Complex Network Analysis and Visualization [42].”
MethodFRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708
Patrick, D. L., Drossman, D. A., Frederick, I. O., Dicesare, J., & Puder, K. L. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018831127942 · Cited by 761 · cited 4×
“At each assessment, participants were also administered validated disease-specific instruments—the IBS Quality of Life (IBS-QOL), the IBS Symptom Severity Index (IBS-SSI), and the IBD Questionnaire (IBD-Q)—to assess the disease-specific impact of the intervention.”
MethodInfluentialCreswell, J. D., Irwin, M. R., Burklund, L. J., Lieberman, M. D., Arevalo, J. M. G., Ma, J., Breen, E. C., & Cole, S. W. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.006 · Cited by 607 · cited 1×
“, mindfulness-based stress reduction and cognitive-behavioral stress management) have been shown to have similar effects on NF-κB and other pro-inflammatory molecules [29,30].”
BackgroundMittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., Tillinger, W., Gangl, A., & Moser, G. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000106907.24881.f2 · Cited by 532 · cited 1×
“In IBD, similar studies have suggested that stress may be a risk for IBD flares of all types [19] and that depression may be a predisposing factor for the development of one of the IBD subtypes, Crohn’s disease [20].”
BackgroundBhasin, M. K., Dusek, J. A., Chang, B.-H., Joseph, M. G., Denninger, J. W., Fricchione, G. L., Benson, H., & Libermann, T. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062817 · Cited by 304
Self-citationCognitive-Behavioral Stress Management Reverses Anxiety-Related Leukocyte Transcriptional Dynamics
Antoni, M. H., Lutgendorf, S. K., Blomberg, B., Carver, C. S., Lechner, S., Diaz, A., Stagl, J., Arevalo, J. M. G., & Cole, S. W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.007 · Cited by 251 · cited 1×
“, mindfulness-based stress reduction and cognitive-behavioral stress management) have been shown to have similar effects on NF-κB and other pro-inflammatory molecules [29,30].”
BackgroundGenomic counter-stress changes induced by the relaxation response
Dusek, J. A., Otu, H. H., Wohlhueter, A. L., Bhasin, M., Zerbini, L. F., Joseph, M. G., Benson, H., & Libermann, T. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002576 · Cited by 248
Self-citationPsychological interventions for treatment of inflammatory bowel disease
Timmer, A., Preiss, J. C., Motschall, E., Rücker, G., Jantschek, G., & Moser, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006913.pub2 · Cited by 187 · cited 2×
“, 3-months) [12]; however, the durability of these interventions was less clear [13].”
BackgroundPsychological treatments for the management of irritable bowel syndrome
Zijdenbos, I. L., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Quartero, A. O. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006442.pub2 · Cited by 180 · cited 1×
“, 3-months) [12]; however, the durability of these interventions was less clear [13].”
BackgroundMitogen activated protein kinases: a role in inflammatory bowel disease?
Broom, O. J., Widjaya, B., Troelsen, J., Olsen, J., & Nielsen, O. H. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04033.x · Cited by 177 · cited 2×
“Studies using both gene expression profiling and protein-based assays have shown activation of Mitogen-activated protein kinases (MAPK) to be important in IBD [59].”
BackgroundMethodLackner, J. M., Jaccard, J., Krasner, S. S., Katz, L. A., Gudleski, G. D., & Blanchard, E. B. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.014 · Cited by 172
Ananthakrishnan, A. N., Khalili, H., Pan, A., Higuchi, L. M., de Silva, P., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.08.032 · Cited by 155
A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome
Blanchard, E. B., Lackner, J. M., Sanders, K., Krasner, S., Keefer, L., Payne, A., Gudleski, G. D., Katz, L., Rowell, D., Sykes, M., et al. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.07.003 · Cited by 121 · cited 1×
“A number of studies have demonstrated the beneficial impact of non-pharmacological therapies for IBS, for example, hypnosis, cognitive behavioral therapy (CBT), and stress management education [2–4].”
BackgroundLowén, M. B. O., Mayer, E. A., Sjöberg, M., Tillisch, K., Naliboff, B., Labus, J., Lundberg, P., Ström, M., Engström, M., & Walter, S. A. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12319 · Cited by 121 · cited 1×
“recently demonstrated that the abnormal processing and enhanced perception of visceral stimuli in IBS can be normalized by both hypnotherapy and an educational intervention [57].”
BackgroundMizrahi, M. C., Reicher-Atir, R., Levy, S., Haramati, S., Wengrower, D., Israeli, E., & Goldin, E. (2012) · Psychology & Health · doi:10.1080/08870446.2012.691169 · Cited by 83 · cited 1×
“In addition, a recent randomized controlled trial of three relaxation-training sessions and at home practice of guided imagery compared to a wait-list control showed improvements in quality of life and mood, as well as decreases in pain and stress in IBD patients [21].”
BackgroundLabus, J., Gupta, A., Gill, H. K., Posserud, I., Mayer, M., Raeen, H., Bolus, R., Simren, M., Naliboff, B. D., & Mayer, E. A. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12171 · Cited by 64
Complementary and alternative medicine for IBS in adults: mind-body interventions.
Kearney, D. J., & Brown-Chang, J. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1257 · Cited by 57 · cited 1×
“Studies suggest that patients with IBS benefit more from CBT treatment than from routine medical care alone [3].”
BackgroundIrritable bowel syndrome treatment: Cognitive behavioral therapy versus medical treatment
Mahvi-Shirazi, M., Fathi-Ashtiani, A., Rasoolzade-Tabatabaei, S.-K., & Amini, M. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.27292 · Cited by 40 · cited 1×
“Since 2009, a number of larger clinical trials in IBS using a variety of psychological modalities have confirmed the short-term benefit of both individual and group sessions [4,13–18].”
Background
Cited by
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189
“Also mindfulness-based therapy (207), a comprehensive mind-body program (208), meditation (209), mind-body alternative approaches (210), yoga (211), and relaxation response-based mind-body interventions (212) have shown to be beneficial for IBD patients.”
BackgroundDrossman, D. A., Tack, J., Ford, A. C., Szigethy, E., Törnblom, H., & Van Oudenhove, L. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.279 · Cited by 470
Traylor, C. S., Johnson, J. D., Kimmel, M. C., & Manuck, T. A. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100229 · Cited by 320
Mind–body therapy via videoconferencing in patients with neurofibromatosis: An RCT
Vranceanu, A.-M., Riklin, E., Merker, V. L., Macklin, E. A., Park, E. R., & Plotkin, S. R. (2016) · Neurology · doi:10.1212/wnl.0000000000003005 · Cited by 85
Self-citationMachine learning predictive outcomes modeling in inflammatory bowel diseases
Javaid, A., Shahab, O., Adorno, W., Fernandes, P., May, E., & Syed, S. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab187 · Cited by 36
Metadata
- Authors
- Kuo, B., Bhasin, M., Jacquart, J., Scult, M. A., Slipp, L., Riklin, E. I. K., Lepoutre, V., Comosa, N., Norton, B.-A., Dassatti, A., Rosenblum, J., Thurler, A. H., Surjanhata, B. C., Hasheminejad, N. N., Kagan, L., Slawsby, E., Rao, S. R., Macklin, E. A., Fricchione, G. L., Benson, H., Libermann, T. A., Korzenik, J., & Denninger, J. W.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-04-30
- Volume
- 10
- Issue
- 4
- Pages
- e0123861
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2147656839
- Cited by
- 84
- References
- 23
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.